Literature DB >> 3317840

Thrombospondin in clinical disease states.

W J Booth1, M C Berndt.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3317840     DOI: 10.1055/s-2007-1003505

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  5 in total

1.  Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis.

Authors:  Pratik Desai; Jeffrey J Stein; Sufyan A Siddiqui; Kristopher G Maier; Vivian Gahtan
Journal:  Mol Cell Biochem       Date:  2015-09-08       Impact factor: 3.396

2.  Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

3.  Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts.

Authors:  Ieva Janulaityte; Andrius Januskevicius; Airidas Rimkunas; Jolita Palacionyte; Astra Vitkauskiene; Kestutis Malakauskas
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

4.  Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.

Authors:  M Herrmann; S J Suchard; L A Boxer; F A Waldvogel; P D Lew
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.

Authors:  Ling-Yun Chu; Devi Prasadh Ramakrishnan; Roy L Silverstein
Journal:  Blood       Date:  2013-07-29       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.